PDL Quest Diagnostics

This contract involves the purchase of 4,680 deidentified nasopharyngeal specimens, which will be selected weekly at random. The specimens include 20 that test positive for Bordetella pertussis, 20 positive for other Bordetella species, and 5 negative samples. All samples will be provided in their original collection containers and labeled with a study identification number. To ensure preservation and integrity, the specimens will be stored frozen at -70°C and shipped overnight on dry ice. The contract is issued by the Centers for Disease Control and Prevention (CDC) and is associated with PDL Quest Diagnostics. Key personnel involved include Marybeth Culp as the program point of contact and an unnamed contracting officer. While the solicitation number and set-aside details are not provided, this procurement is forecasted to support ongoing research or diagnostic efforts related to Bordetella species, with an emphasis on maintaining specimen quality through appropriate storage and handling conditions.